A protocol designed for primary care increased weight loss across a quarter of a million people, but only 25% of those with a ...

One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 ...

More than 90% of patients achieved clinically meaningful weight reduction compared to placebo in a phase 3 trial of ecnoglutide.

Phase 3 data support use of the oral non-peptide small molecule as potential first-line type 2 diabetes treatment, investigator says.

Duke clinicians and patients discuss how approaches such as talk, music, and art therapy can address psychosocial issues that cancer survivors often face. Beyond Cancer: Building Bridges Experts ...

The dapivirine ring was originally approved in July 2020 to reduce the risk for HIV-1 infection in women 18 years and older ...

The European agency has started a review of sodium oxybate to assess its use to treat alcohol withdrawal syndrome and support ...

Portugal fails to report mental health data of its incarcerated population to the World Health Organization, reflecting ...

Many established medical therapies to treat myasthenia gravis remain in use, and newer options are available for patients who ...

Initiating intensive blood pressure lowering soon after ICH is linked to better outcomes compared to currently recommended ...

Dupilumab has been approved by the FDA for the treatment bullous pemphigoid in adults, the manufacturer Regeneron announced.

Switching from diet sodas to water may help women with type 2 diabetes and obesity or overweight lose more weight and improve ...